Matches in Wikidata for { <http://www.wikidata.org/entity/Q99366098> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q99366098 description "2020 թվականի սեպտեմբերի 11-ին հրատարակված գիտական հոդված" @default.
- Q99366098 description "article scientifique publié en 2020" @default.
- Q99366098 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99366098 description "scientific article published on 11 September 2020" @default.
- Q99366098 description "wetenschappelijk artikel" @default.
- Q99366098 description "наукова стаття, опублікована 11 вересня 2020" @default.
- Q99366098 name "Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS s" @default.
- Q99366098 name "Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS s" @default.
- Q99366098 type Item @default.
- Q99366098 label "Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS s" @default.
- Q99366098 label "Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS s" @default.
- Q99366098 prefLabel "Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS s" @default.
- Q99366098 prefLabel "Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS s" @default.
- Q99366098 P1433 Q99366098-F52B74E3-8C7D-4A35-B5F8-4DD158EF5AE6 @default.
- Q99366098 P1476 Q99366098-96E924EF-B225-4D8D-A81F-C7CA9FADA870 @default.
- Q99366098 P2093 Q99366098-08869BF7-73C4-4BBF-A002-F6BAEF89FA5D @default.
- Q99366098 P2093 Q99366098-47AA495C-CF8E-4F48-9C63-9157F45DA675 @default.
- Q99366098 P2093 Q99366098-48D953FC-2EFB-4196-9C17-10079709B983 @default.
- Q99366098 P2093 Q99366098-65270C53-F592-4BA8-AD19-12AB40A06165 @default.
- Q99366098 P2093 Q99366098-7E3BCBA8-E2F0-4D6B-BA2D-81878ECFF649 @default.
- Q99366098 P2093 Q99366098-86D7CE68-71A8-4980-81E6-2A6DED4540AA @default.
- Q99366098 P2093 Q99366098-8A36EF9E-D27D-4947-86D8-31126E427C0D @default.
- Q99366098 P2093 Q99366098-97820179-041E-44A0-BD17-39ECF6943508 @default.
- Q99366098 P2093 Q99366098-C5CC89A4-77F4-4086-91A3-3C82FD6FAEA8 @default.
- Q99366098 P2093 Q99366098-D49C0861-09D4-4FBC-BB95-B32D2294EB34 @default.
- Q99366098 P2093 Q99366098-DA8F5D8E-AE77-42DB-9DE4-F35B8AB2917D @default.
- Q99366098 P2093 Q99366098-E46E86F7-056F-4F60-BC2E-4F59BA8B2E24 @default.
- Q99366098 P2093 Q99366098-EFAD57C7-1098-4644-8DEF-AC3F9A3F3F08 @default.
- Q99366098 P2093 Q99366098-FEFBA3D9-60E3-486F-97E6-7279FD54BCE7 @default.
- Q99366098 P31 Q99366098-07347159-75DB-4103-BE73-E9274C0A16B0 @default.
- Q99366098 P356 Q99366098-E020A82A-B94A-4D0C-B85E-6081D888951D @default.
- Q99366098 P50 Q99366098-56D7F4B0-2DCB-42C8-93B2-7ECC92FA9A99 @default.
- Q99366098 P577 Q99366098-3B156648-DFB7-47E3-BE59-8A4F9FA6D514 @default.
- Q99366098 P698 Q99366098-F4AA2224-C3E0-4A91-95DA-A83F461E8A07 @default.
- Q99366098 P356 S00520-020-05765-7 @default.
- Q99366098 P698 32918131 @default.
- Q99366098 P1433 Q15766919 @default.
- Q99366098 P1476 "Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS study, NCCH-1512)" @default.
- Q99366098 P2093 "Eisaku Miyauchi" @default.
- Q99366098 P2093 "Haruhiko Fukuda" @default.
- Q99366098 P2093 "Katsuko Kikuchi" @default.
- Q99366098 P2093 "Keiko Nozawa" @default.
- Q99366098 P2093 "Naoya Yamazaki" @default.
- Q99366098 P2093 "Ryota Saito" @default.
- Q99366098 P2093 "Taro Shibata" @default.
- Q99366098 P2093 "Tetsu Kobayashi" @default.
- Q99366098 P2093 "Tetsuya Hamaguchi" @default.
- Q99366098 P2093 "Toshiaki Takahashi" @default.
- Q99366098 P2093 "Yasuo Nakai" @default.
- Q99366098 P2093 "Yoshio Kiyohara" @default.
- Q99366098 P2093 "Yuichiro Ohe" @default.
- Q99366098 P2093 "Yutaka Fujiwara" @default.
- Q99366098 P31 Q13442814 @default.
- Q99366098 P356 "10.1007/S00520-020-05765-7" @default.
- Q99366098 P50 Q99366095 @default.
- Q99366098 P577 "2020-09-11T00:00:00Z" @default.
- Q99366098 P698 "32918131" @default.